# Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes

> **NCT00509925** · PHASE4 · TERMINATED · sponsor: **Novo Nordisk A/S** · enrollment: 23 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin NPH
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00509925
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** See detailed description
- **Last updated:** 2017-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509925, "Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00509925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*